Press Releases
Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
Data and Safety Monitoring Board Reviews Cohort 1 Safety Data and Approves Dosing Cohort 2 in the Clinical Trial of OCU200—a Novel Fusion Protein for Diabetic Macular Edema
Wednesday, March 19, 2025Ocugen Inca pioneering biotechnology leader in gene therapies for blindness diseases today announced that the Data and Safety Monitoring Board DSMB for the OCU clinical trial recently convened and reviewed safety data following dosing of the first co...
EnteroBiotix Announces Positive Topline Phase 2a Results with EBX-102-02, a Potential First-in-Class Treatment for Irritable Bowel Syndrome (IBS)
Wednesday, March 19, 2025EnteroBiotix Limited a clinicalstage biopharmaceutical company focussed on developing bestinclass drugs for gut health today announced positive initial results with EBX the Companys nextgeneration fullspectrum microbiome product from the TrIuMPH Phas...
Precision BioSciences Announces Clearance of Investigational New Drug Application by the U.S. FDA for First-in-Class PBGENE-HBV Designed to Eliminate Root Cause of Chronic Hepatitis B
Tuesday, March 18, 2025Precision BioSciences Inc Nasdaq DTIL a clinical stage gene editing company utilizing its novel proprietary ARCUS platform to develop in vivo gene editing therapies for high unmet need diseases today announced that the US Food and Drug Administration...
Imfinzi approved in the EU as first and only immunotherapy for limited-stage small cell lung cancer
Monday, March 17, 2025AstraZenecas Imfinzi durvalumab has been approved in the European Union EU as monotherapy for the treatment of adults with limitedstage small cell lung cancer LSSCLC whose disease has not progressed following platinumbased chemoradiation therapy CRT
Salipro Biotech and Boehringer Ingelheim Enter Research and License Agreement to Accelerate Multiple Boehringer Ingelheim Pipeline Programs
Friday, March 14, 2025Salipro Biotech AB a Swedish biotech company specialising in the stabilisation of challenging drug targets today announced a research and license agreement with Boehringer Ingelheim to accelerate the development of multiple drug targets This collabor...
Medigene Files Patent for Unique NK-Specific TCR Construct with European Patent Office
Friday, March 14, 2025Medigene AG an oncology platform company focused on the research and development of T cell receptor TCRguided therapies for the treatment of cancer today announced the submission of a patent for a novel natural killer NK cellspecific TCR construct to...
Celonic Group Leverages Merck’s Breez™ Micro-Bioreactor Platform, Enabling Next-Generation Perfusion-Based Bioprocessing
Thursday, March 13, 2025Celonic Group a SwissBased Quality contract development and manufacturing organization CDMO has announced that it is integrating Mercks Breez microbioreactor platform into its process development This addition will further enhance Celonics capabiliti...
PharmaCord and Mercalis to Merge, Creating Next-Generation Platform to Meet Evolving Needs of the Biopharmaceutical Industry
Thursday, March 13, 2025PharmaCord LLC a leading provider of patient services for the biopharmaceutical industry and Mercalis an integrated life sciences commercialization partner that provides comprehensive solutions that span the entire healthcare value chain today announ...
OSE Immunotherapeutics and GERCOR Announce Positive Topline Phase 2 Result for Clinical Trial TEDOPaM Evaluating OSE2101 (Tedopi®) in Advanced Pancreatic Cancer
Wednesday, March 12, 2025OSE Immunotherapeutics SA and the GERCOR Group today announced that the primary endpoint has been reached in TEDOPaM GERCOR D PRODIGE trial a Phase clinical trial sponsored and conducted by the French GERCOR Oncology Clinician Group evaluating OSE
Vetter boosts pharmaceutical storage capacity with major warehouse expansion
Wednesday, March 12, 2025Vetter a globally operating Contract Development and Manufacturing Organization CDMO announces a significant expansion of its pharmaceutical materials warehouse in Ravensburg to meet increasing market demand and support the companys organic growth Wi...
